André L. Mihaljević
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 39
- Surgery top 2%
- Pancreatitis Pathology and Treatment 19
- Esophageal and GI Pathology 9
-
- Gastric Cancer Management and Outcomes 11
- Gallbladder and Bile Duct Disorders 11
- Renal cell carcinoma treatment 8
- Gastroenterology top 5%
- Cancer Research top 10%
-
- Neuroendocrine Tumor Research Advances 12
-
- Cardiac, Anesthesia and Surgical Outcomes 11
- Co-authors
- Markus W. BüchlerThilo HackertPascal ProbstMarkus K. DienerUlla KlaiberPatrick HegerOliver StrobelJörg Kleeff
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
André L. Mihaljević
106 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 1.3k
- Surgery 1.3k
- Pulmonary and Respiratory Medicine 808
- Gastroenterology 126
- Cancer Research 225
Countries citing papers authored by André L. Mihaljević
This map shows the geographic impact of André L. Mihaljević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André L. Mihaljević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André L. Mihaljević more than expected).
Fields of papers citing papers by André L. Mihaljević
This network shows the impact of papers produced by André L. Mihaljević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André L. Mihaljević. The network helps show where André L. Mihaljević may publish in the future.
Co-authorship network
The 25 scholars most cited alongside André L. Mihaljević, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trialbreakdown → | 2024 | 47 |
| 3 | 2024 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 29 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 14 | |
| 17 | 2020 | 6 | |
| 18 | 2020 | 9 | |
| 19 | 2019 | 9 | |
| 20 | 2019 | 117 |
About André L. Mihaljević
André L. Mihaljević is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 113 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (39 papers), Pancreatitis Pathology and Treatment (19 papers), Neuroendocrine Tumor Research Advances (12 papers), Gastric Cancer Management and Outcomes (11 papers), Cardiac, Anesthesia and Surgical Outcomes (11 papers), Gallbladder and Bile Duct Disorders (11 papers), Esophageal and GI Pathology (9 papers) and Renal cell carcinoma treatment (8 papers). The work is most often cited by research in Oncology (1.3k citations), Surgery (1.3k citations) and Pulmonary and Respiratory Medicine (808 citations). André L. Mihaljević has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Markus W. Büchler, Thilo Hackert, Pascal Probst, Markus K. Diener, Ulla Klaiber, Patrick Heger, Oliver Strobel, Jörg Kleeff, Arianeb Mehrabi and Ulrike Heger.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.